Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology.

Meerpoel L, Backx LJ, Van der Veken LJ, Heeres J, Corens D, De Groot A, Odds FC, Van Gerven F, Woestenborghs FA, Van Breda A, Oris M, van Dorsselaer P, Willemsens GH, Vermuyten KJ, Marichal PJ, Vanden Bossche HF, Ausma J, Borgers M.

J Med Chem. 2005 Mar 24;48(6):2184-93.

PMID:
15771461
2.

The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis.

Vanden Bossche H, Ausma J, Bohets H, Vermuyten K, Willemsens G, Marichal P, Meerpoel L, Odds F, Borgers M.

Antimicrob Agents Chemother. 2004 Sep;48(9):3272-8.

3.

Accumulation of 3-ketosteroids induced by itraconazole in azole-resistant clinical Candida albicans isolates.

Marichal P, Gorrens J, Laurijssens L, Vermuyten K, Van Hove C, Le Jeune L, Verhasselt P, Sanglard D, Borgers M, Ramaekers FC, Odds F, Vanden Bossche H.

Antimicrob Agents Chemother. 1999 Nov;43(11):2663-70.

4.

Azole antifungals: weak inhibitors of inducible nitric oxide synthase in mouse and human cells.

Vermuyten K, Laurijssens L, Vanden Bossche H.

Mycoses. 1997 Sep;40(3-4):119-25.

PMID:
9375500
6.

A serum protein involved in aging?

Ai KZ, Vermuyten K, De Deyn PP, Lowenthal A, Karcher D.

Mol Chem Neuropathol. 1989 Dec;11(3):131-41.

PMID:
2485632

Supplemental Content

Loading ...
Support Center